These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 4016931

  • 41. Neuroendocrine and behavioral effects of flunarizine in young and old rats.
    Drago F, Continella G, Mangano O, Canonico PL, Bernardini R, Scapagnini U.
    Cephalalgia; 1985 May; 5 Suppl 2():125-9. PubMed ID: 4016925
    [Abstract] [Full Text] [Related]

  • 42. Flunarizine, a new preventive approach to migraine. A double-blind comparison with placebo.
    Frenken CW, Nuijten ST.
    Clin Neurol Neurosurg; 1984 May; 86(1):17-20. PubMed ID: 6325065
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Protection with flunarizine against hypoxic-ischaemic damage of the rat cerebral cortex. A quantitative morphologic assessment.
    Van Reempts J, Borgers M, Van Dael L, Van Eyndhoven J, Van De Ven M.
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):76-88. PubMed ID: 6870389
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Effects of calcium antagonists on serotonin-dependent aggregation and serotonin transport in platelets of patients with migraine.
    Pukhal'skaya TG, Kolosova OA, Men'shikov MY, Vein AM.
    Bull Exp Biol Med; 2000 Jul; 130(7):633-5. PubMed ID: 11140571
    [Abstract] [Full Text] [Related]

  • 48. Vasodilating effect of flunarizine in anesthetized dogs.
    Kato H, Kurihara J, Ishii K, Kasuya Y.
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):257-63. PubMed ID: 7224725
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Agents to improve cerebrovascular circulation and cerebral metabolism--flunarizine].
    Kurihara J, Kato H.
    Nihon Rinsho; 1985 Feb; 43(2):402-5. PubMed ID: 3889415
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Flunarizine in the treatment of arteriopathies of the legs].
    Catalano M, Sacchi E, Tomasini M, Coazzoli E, Parolini A, Dall'Oglio A, Libretti A.
    Ric Clin Lab; 1985 Feb; 15 Suppl 1():475-8. PubMed ID: 4035228
    [Abstract] [Full Text] [Related]

  • 54. Flunarizine treatment for spur cell anaemia.
    Fossaluzza V, Rossi P.
    Br J Haematol; 1983 Dec; 55(4):715-7. PubMed ID: 6671091
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blocker.
    De Clerck F, Loots W, Somers Y, Van Gorp L, Verheyen A, Wouters L.
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):4-23. PubMed ID: 2990365
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. In vitro effects of flunarizine on human lymphocytes.
    Brohée D, Piro P, Kennes B, Nève P.
    Cytobios; 1986 Mar; 45(182-183):139-46. PubMed ID: 3731875
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.